
Windermere Research & Hospitals Private Limited
Establishes and manages healthcare facilities, conducts medical tests and research, and publishes medical data.
Establishes and manages healthcare facilities, conducts medical tests and research, and publishes medical data.
Windermere Research & Hospitals Private Limited (WRHPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 April 2020 (Five years and one month 2 days old ). Its registered office is in Khasi Hills, Meghalaya, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹34.00 Cr.
Pramod Sharma, Charles Pyngrope, and Rahul Agarwal serve as directors at the Company.
Khasi Hills, Meghalaya, India
+91-XXXXXXXXXX
U93090ML2020PTC013723
013723
Private Limited Indian Non-Government Company
06 Apr 2020
30 Sep 2023
31 Mar 2023
Unlisted
Roc Shillong
Name | Designation | Appointment Date | Status |
---|---|---|---|
Charles Pyngrope ![]() | Director | 06-Apr-2020 | Current |
Pramod Sharma ![]() | Director | 06-Apr-2020 | Current |
Rahul Agarwal ![]() | Director | 06-Apr-2020 | Current |
Windermere Research & Hospitals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1081.59% increase. The company also saw a substantial improvement in profitability, with a 1081.95% increase in profit. The company's net worth moved up by a moderate rise of 2.68%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
Unlock access to Windermere Research & Hospitals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Pramod Sharma is a mutual person
Pramod Sharma is a mutual person
Pramod Sharma is a mutual person
Pramod Sharma is a mutual person
Pramod Sharma is a mutual person
Pramod Sharma is a mutual person
₹34.00 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
02 Aug 2022 | North Eastern Development Finance Corporation Limited | ₹34.00 Cr | Open |
Windermere Research & Hospitals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Windermere Research & Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Windermere Research & Hospitals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Windermere Research & Hospitals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Windermere Research & Hospitals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Shillong.
A charge with North Eastern Development Finance Corporation Limited amounted to Rs. 34.00 Cr with Charge ID 100603509 was registered on 02 Aug 2022.
Pramod Kumar Sharma was appointed as a Director was appointed as a Director on 06 Apr 2020 & has been associated with this company since 5 years 1 month .
Charles Pyngrope was appointed as a Director was appointed as a Director on 06 Apr 2020 & has been associated with this company since 5 years 1 month .
Rahul Agarwal was appointed as a Director was appointed as a Director on 06 Apr 2020 & has been associated with this company since 5 years 1 month .
Windermere Research & Hospitals Private Limited was incorporated on 06 Apr 2020.
The authorized share capital of Windermere Research & Hospitals Private Limited is ₹ 9.00 Cr and paid-up capital is ₹ 9.00 Cr.
Currently 3 directors are associated with Windermere Research & Hospitals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Windermere Research & Hospitals Private Limited is C/O Charles Pyngrope Hosanna Pohkseh P.O.-Rynjah, India, Shillong, Meghalaya, 793006.
The corporate identification number (CIN) of Windermere Research & Hospitals Private Limited is U93090ML2020PTC013723 and the company number is 013723 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Windermere Research & Hospitals Private Limited has risen by 1081.59%.
The financial reports for the fiscal year 2023 indicates that The net worth of Windermere Research & Hospitals Private Limited has experienced an upsurge of 2.68%.
As per the financial statements for fiscal Year 2023, The total open charges for Windermere Research & Hospitals Private Limited amount to ₹ 34.00 Cr.
The most recent Balance Sheet for Windermere Research & Hospitals Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.